From Breakthrough to Blockbuster cover art

From Breakthrough to Blockbuster

The Business of Biotechnology

Preview
Get this deal Try Premium Plus free
Offer ends 29 January 2026 at 11:59PM GMT.
Prime members: New to Audible? Get 2 free audiobooks during trial.
Just £0.99/mo for your first 3 months of Audible.
1 bestseller or new release per month—yours to keep.
Listen all you want to thousands of included audiobooks, podcasts, and Originals.
Auto-renews at £8.99/mo after 3 months. Cancel monthly.
Pick 1 audiobook a month from our unmatched collection - including bestsellers and new releases.
Listen all you want to thousands of included audiobooks, Originals, celeb exclusives, and podcasts.
Access exclusive sales and deals.
£8.99/month after 30 days. Renews automatically.

From Breakthrough to Blockbuster

By: Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos
Narrated by: Chris Andrew Ciulla
Get this deal Try Premium Plus free

£8.99/mo after 3 months. Cancel monthly. Offer ends 29 January 2026 at 11:59PM GMT.

£8.99/month after 30 days. Renews automatically. See here for eligibility.

Buy Now for £12.99

Buy Now for £12.99

LIMITED TIME OFFER | £0.99/mo for the first 3 months

Premium Plus auto-renews at £8.99/mo after 3 months. Terms apply.

About this listen

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources.

Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs.

From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.

©2022 Oxford University Press (P)2022 Ascent Audio
Biological Sciences Biotechnology Business Development & Entrepreneurship Entrepreneurship Medicine & Health Care Industry Pharmacology Science Business Medicine

Listeners also enjoyed...

The Billion Dollar Molecule cover art
The Price of Health cover art
A Prescription for Change cover art
Genentech cover art
Why Not Better and Cheaper? cover art
Completing Capitalism cover art
Corporate Innovation in the Fifth Era cover art
The Risk-Driven Business Model cover art
For Blood and Money cover art
Enduring Success cover art
The First Mile cover art
Go Tech, or Go Extinct cover art
The Imperfectionists cover art
The Comprehensive Guide to Clinical Research cover art
The Genome Odyssey cover art
Gene Machine cover art
No reviews yet